COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.

Background Patients with cancer are purported to have poor COVID-19 outcomes. However, cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour subtypes. The aim of this study was to investigate COVID-19 risk according to tumour subtype and patient demographics in patients with...

Full description

Bibliographic Details
Main Authors:	Lee, LYW, Cazier, J-B, Starkey, T, Briggs, SEW, Arnold, R, Bisht, V, Booth, S, Campton, NA, Cheng, VWT, Collins, G, Curley, HM, Earwaker, P, Fittall, MW, Gennatas, S, Goel, A, Hartley, S, Hughes, DJ, Kerr, D, Lee, AJX, Lee, RJ, Lee, SM, Mckenzie, H, Middleton, CP, Murugaesu, N, Newsom-Davis, T, Olsson-Brown, AC, Palles, C, Powles, T, Protheroe, EA, Purshouse, K, Sharma-Oates, A, Sivakumar, S, Smith, AJ, Topping, O, Turnbull, CD, Várnai, C, Briggs, ADM, Middleton, G, Kerr, R, UK Coronavirus Cancer Monitoring Project Team
Format:	Journal article
Language:	English
Published:	Elsevier 2020

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.

Similar Items